Newsroom

Stay up-to-date on our breakthroughs and innovations with the latest news and media coverage.

Latest News

Delve Bio Continues to Bolster Data on Metagenomic Sequencing Utility for Diagnosing CNS Infections

GENOME WEB

READ MORE
Earlier Use of Metagenomic (mNGS) Testing Can Reduce Number of Tests Performed and Days to Diagnosis of Meningitis/Encephalitis

BUSINESS WIRE

READ MORE
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis

BUSINESS WIRE

READ MORE
New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis

BUSINESS WIRE

READ MORE

Press Releases

January 22, 2026

Earlier Use of Metagenomic (mNGS) Testing Can Reduce Number of Tests Performed and Days to Diagnosis of Meningitis/Encephalitis

November 14, 2025

Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis

October 20, 2025

New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis

May 08, 2025

New Data Show Delve Bio’s Metagenomic Platform Accurately Identifies Viruses and Their Subtypes With a Single Test

April 07, 2025

Delve Bio to Present on Metagenomic Next Generation Sequencing (mNGS) at the American Academy of Neurology 2025 Annual Meeting

December 04, 2024

Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect

November 21, 2024

Delve Bio Presents Data Showing Metagenomic Next-Generation Sequencing (mNGS) Delivers Greater Diagnostic Yield Than Conventional Methods in Central Nervous System Infections

November 12, 2024

Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections

October 09, 2024

Delve Bio Announces Partnership with Broad Clinical Labs for Metagenomic Next Generation Sequencing (mNGS)

June 17, 2024

Delve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections

April 17, 2024

Delve Bio presents study showing utility of metagenomic next generation sequencing (mNGS) in diagnosing neurological infections

June 20, 2023

Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis
See All Press Releases

Media

January 29, 2026

Delve Bio Continues to Bolster Data on Metagenomic Sequencing Utility for Diagnosing CNS Infections

July 02, 2025

Delve Bio Reduces Turnaround Time for Agnostic Pathogen Detection Service

March 20, 2025

FDA official’s quest gave hope to a girl with balamuthia

December 16, 2024

Diagnostic Discoveries through mNGS

November 15, 2024

Breakthrough Genomic Test Can Diagnose Nearly Any Infection

November 13, 2024

Metagenomic sequencing improves detection of rare pathogens in CNS infections

November 13, 2024

Metagenomics Enables Diagnosing Nearly All Pathogens with a Single Test

November 12, 2024

Seven-Year Study Validates Metagenomic Sequencing for Diagnosing CNS Infections

November 12, 2024

Genetic test might quickly diagnose any type of infection

November 12, 2024

1 Genomic Test Can Diagnose Nearly Any Infection

November 12, 2024

Cutting-edge test uses DNA sequencing to yield diagnoses for some medical mysteries

October 09, 2024

Delve Bio, Broad Clinical Labs Partner for Metagenomic Infectious Disease Sequencing
See All Media

Start today with Delve Detect

Contact Us